Gleneagles Global Hospitals

Haemonetics Announces European Expansion for VASCADE® Vascular Closure System

Retrieved on: 
Tuesday, August 29, 2023

This marks the first use of the VASCADE system portfolio, widely used in U.S. hospitals, in a European country.

Key Points: 
  • This marks the first use of the VASCADE system portfolio, widely used in U.S. hospitals, in a European country.
  • The VASCADE system is designed for "small-bore" femoral arterial and venous closure, generally used in interventional cardiology and peripheral vascular procedures.
  • The VASCADE MVP system is designed for "mid-bore" multi-access femoral venous closure, generally used in electrophysiology procedures.
  • Haemonetics is planning further expansion for the VASCADE system portfolio in other markets outside the U.S.

Mytonomy Named to AVIA Marketplace's Top Oncology Companies

Retrieved on: 
Thursday, August 17, 2023

BETHESDA, Md., Aug. 17, 2023 /PRNewswire-PRWeb/ -- Mytonomy, Inc., a leader in healthcare cloud solutions for video-based patient education and engagement, announced today that it has been recognized as a Top Reviewed Company in Oncology, following thorough research and industry outreach by AVIA Marketplace, the premier digital health marketplace where innovative health systems and hospitals go to find the right digital health solutions.

Key Points: 
  • -- Anjali Kataria, CEO and Co-founder
    Mytonomy Cloud for Healthcare delivers over 3,000 clinical video episodes, covering more than 100 medical conditions and procedures, including oncology.
  • Mytonomy's curated oncology content covers a range of topics from cancer detection and risk factors to pain management and shared decision making.
  • The Top Oncology Companies Report is a synthesis and examination of client ratings, reviews, and healthcare system implementation data from all over the country.
  • This report highlights industry trends and underscores the profound impact these companies and their products are making in the field.

Vivasure Medical Announces FDA IDE Approval to Initiate U.S. Pivotal Study

Retrieved on: 
Monday, March 13, 2023

Vivasure Medical® Limited (“Vivasure” or the “Company”), a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that the U.S. Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) to advance the company’s PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and effectiveness of the Vivasure PerQseal® Closure Device System.

Key Points: 
  • Vivasure Medical® Limited (“Vivasure” or the “Company”), a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that the U.S. Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) to advance the company’s PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and effectiveness of the Vivasure PerQseal® Closure Device System.
  • The PATCH pivotal study will enroll up to 188 patients across the U.S. and Europe.
  • The company intends to use the clinical study results to support an FDA pre-market approval submission as well as multinational commercial launch of the PerQseal system for large hole vessel closure.
  • The strategic investment by Haemonetics includes an option to acquire Vivasure Medical upon completion of certain milestones.

Outlook on the Hospital Capacity Management Solutions Global Market to 2027 - Integration of Advanced Technologies in Hospital Capacity Management Solution Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 27, 2022

Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hospital Capacity Management Solutions Market?

Key Points: 
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hospital Capacity Management Solutions Market?
  • What is the competitive strategic window for opportunities in the Global Hospital Capacity Management Solutions Market?
  • What is the market share of the leading vendors in the Global Hospital Capacity Management Solutions Market?
  • What modes and strategic moves are considered suitable for entering the Global Hospital Capacity Management Solutions Market?

Global Hospital Market to 2026 - Featuring Spire Healthcare, Universal Health Services and ORPEA Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 25, 2022

The Global Hospital Market has been segmented based on ownership, type, type of services, bed capacity, region, and company.

Key Points: 
  • The Global Hospital Market has been segmented based on ownership, type, type of services, bed capacity, region, and company.
  • To estimate and forecast the market size of the Global Hospital Market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast the Global Hospital Market based on ownership, type, type of services, bed capacity, company, and region.
  • To examine competitive developments such as expansions, new service launches, mergers & acquisitions, etc., in the Global Hospital Market.

Global Hospital Capacity Management Solutions Market Outlook to 2027: Increased Adoption of Real Time Locating Systems - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 19, 2021

Also, the increase in adoption of real time locating systems is expected to propel the global hospital capacity management solution market.

Key Points: 
  • Also, the increase in adoption of real time locating systems is expected to propel the global hospital capacity management solution market.
  • Potential security breaches of data is expected to hinder the growth of the global hospital capacity management solution market.
  • Furthermore, poor integration of tools into existing workflows is also expected to hamper the global hospital capacity management solution market growth.
  • The North America and Europe are key regions in the global market for hospital capacity management solutions.